Senior Vice President, Biometrics and HEOR
Lixia Wang is Senior Vice President of CTI Biopharma Corp. She is responsible for managing biometrics, health economic and outcome research to support drug development, commercial and business decision. With 24 years’ experience working cross big pharma, and biotech companies, Lixia has increasing responsibilities held multiple leadership positions and successfully supported many products worldwide registrations and reimbursements. Lixia is passionate to bring technology, data science to expedite and improve drug development. Lixia received his Ph.D. in Biostatistics from School of Public Health, University of South Carolina, had Master in Applied Statistics and Bachelor of Electronic and Computer Engineering.